Involvement of neuroinflammation during brain development in social cognitive deficits in autism spectrum disorder and schizophrenia

Journal of Pharmacology and Experimental Therapeutics

Volumn 358, Issue 3, 2016, Pages 504-515

  Nakagawa, Yutaka ^a   Chiba, Kenji ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CCAAT ENHANCER BINDING PROTEIN; CELECOXIB; COPPER ZINC SUPEROXIDE DISMUTASE; CUPRIZONE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MINOCYCLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; NEUREXIN; NEUROLIGIN; POSTSYNAPTIC DENSITY PROTEIN 95; RANTES; RISPERIDONE; SCATTER FACTOR RECEPTOR; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR FOXP2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

AUTISM; BINDING AFFINITY; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN DEVELOPMENT; BRAIN MATURATION; BRAIN REGION; CELL ACTIVATION; CEREBELLUM DISEASE; COGNITION; COGNITIVE DEFECT; COMMUNICATION DISORDER; CONNECTOME; DISEASE SEVERITY; EMOTIONALITY; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC RISK; HOMEOSTASIS; HUMAN; MATERNAL HYPERTENSION; MENTAL DISEASE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NONVERBAL COMMUNICATION; PATHOGENESIS; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SOCIAL COGNITION; THALAMUS DISEASE; VERBAL COMMUNICATION; ANIMAL; AUTISM SPECTRUM DISORDER; BRAIN; COMPLICATION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; INFLAMMATION; PATHOPHYSIOLOGY; SOCIAL BEHAVIOR;

ANIMALS; AUTISM SPECTRUM DISORDER; BRAIN; COGNITION; HUMANS; INFLAMMATION; SCHIZOPHRENIA; SOCIAL BEHAVIOR;

EID: 84983591643     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.116.234476     Document Type: Review

References (196)

1. Abbott NJ, Rönnbäck L, and Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41-53.
2. Abernethy LJ, Palaniappan M, and Cooke RWI (2002) Quantitative magnetic resonance imaging of the brain in survivors of very low birth weight. Arch Dis Child 87: 279-283.
3. Abrams DA, Lynch CJ, Cheng KM, Phillips J, Supekar K, Ryali S, Uddin LQ, and Menon V (2013) Underconnectivity between voice-selective cortex and reward circuitry in children with autism. Proc Natl Acad Sci USA 110:12060-12065.
4. Aggleton JP, O'Mara SM, Vann SD, Wright NF, Tsanov M, and Erichsen JT (2010) Hippocampal- Anterior thalamic pathways for memory: uncovering a network of direct and indirect actions. Eur J Neurosci 31:2292-2307.
5. Allen G (2005) The cerebellum in autism. Clin Neuropsychiatry 2:321-337.
6. Allen G, Müller R-A, and Courchesne E (2004) Cerebellar function in autism: functional magnetic resonance image activation during a simple motor task. Biol Psychiatry 56:269-278.
7. Anagnostou E and Taylor MJ (2011) Review of neuroimaging in autism spectrum disorders: What have we learned and where we go from here. Mol Autism 2:4.
8. Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, and Sirigu A (2010) Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci USA 107:4389-4394.
9. Aoki Y, Yahata N, Watanabe T, Takano Y, Kawakubo Y, Kuwabara H, Iwashiro N, Natsubori T, Inoue H, and Suga M, et al. (2014) Oxytocin improves behavioural and neural deficits in inferring others' social emotions in autism. Brain 137: 3073-3086.
10. Arking DE, Cutler DJ, Brune CW, Teslovich TM, West K, Ikeda M, Rea A, Guy M, Lin S, and Cook EH Jr, et al. (2008) A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 82:160-164.
11. Asadabadi M, Mohammadi M R, Ghanizadeh A, Modabbernia A, Ashrafi M, Hassanzadeh E, Forghani S, and Akhondzadeh S (2013) Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: A randomized, doubleblind, placebo-controlled trial. Psychopharmacology 225:51-59.
12. Ashwood P, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen RL, Croen LA, Ozonoff S, Pessah IN, and Van de Water J (2008) Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol 204:149-153.
13. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, and Van de Water J (2011a) Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol 232:196-199.
14. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, and Van de Water J (2011b) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25:40-45.
15. Banati RB (2002) Visualising microglial activation in vivo. Glia 40:206-217.
16. Beauchamp MH, Thompson DK, Howard K, Doyle LW, Egan GF, Inder TE, and Anderson PJ (2008) Preterm infant hippocampal volumes correlate with later working memory deficits. Brain 131:2986-2994.
17. Benarroch EE (2011) Circumventricular organs: Receptive and homeostatic functions and clinical implications. Neurology 77:1198-1204.
18. Bilgiç A, Gürkan K, Türkoglu S, Akça OS, Kiliç GJ, and Uslu R (2010) Iron deficiency in preschool children with autistic spectrum disorders. Res Autism Spectr Disord 4:639-644.
19. Blair RJR (2013) The neurobiology of psychopathic traits in youths. Nat Rev Neurosci 14:786-799.
20. Blank H, Anwander A, and von Kriegstein K (2011) Direct structural connections between voice- And face-recognition areas. J Neurosci 31:12906-12915.
21. Bonkowski D, Katyshev V, Balabanov RD, Borisov A, and Dore-Duffy P (2011) The CNS microvascular pericyte: Pericyte- Astrocyte crosstalk in the regulation of tissue survival. Fluids Barriers CNS 8:8.
22. Borgwardt SJ, Riecher-Rössler A, Dazzan P, Chitnis X, Aston J, Drewe M, Gschwandtner U, Haller S, Pflüger M, and Rechsteiner E, et al. (2007) Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry 61: 1148-1156.
23. Bornhorst J, Wehe CA, Hüwel S, Karst U, Galla HJ, and Schwerdtle T (2012) Impact of manganese on and transfer across blood-brain and blood-cerebrospinal fluid barrier in vitro. J Biol Chem 287:17140-17151.
24. Bottmer C, Bachmann S, Pantel J, Essig M, Amann M, Schad LR, Magnotta V, and Schröder J (2005) Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia. Psychiatry Res 140:239-250.
25. Bourgeron T (2009) A synaptic trek to autism. Curr Opin Neurobiol 19:231-234.
26. Bowers JM and Konopka G (2012) The role of the FOXP family of transcription factors in ASD. Dis Markers 33:251-260.
27. Braunschweig D, Krakowiak P, Duncanson P, Boyce R, Hansen RL, Ashwood P, Hertz-Picciotto I, Pessah IN, and Van de Water J (2013) Autism-specific maternal autoantibodies recognize critical proteins in developing brain. Transl Psychiatry 3:e277.
28. Brazier MW, Davies P, Player E, Marken F, Viles JH, and Brown DR (2008) Manganese binding to the prion protein. J Biol Chem 283:12831-12839.
29. Breymann C (2015) Iron deficiency anemia in pregnancy. Semin Hematol 52:339-347.
30. Brito AR, Vasconcelos MM, Domingues RC, Hygino da Cruz LC Jr, Rodrigues L de S, Gasparetto EL, and Calçada CABP (2009) Diffusion tensor imaging findings in school- Aged autistic children. J Neuroimaging 19:337-343.
31. Brown AS (2011) The environment and susceptibility to schizophrenia. Prog Neurobiol 93:23-58.
32. Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, and Jones IM (1999) Normal prion protein has an activity like that of superoxide dismutase. Biochem J 344:1-5.
33. Cannon M, Caspi A, Moffitt TE, Harrington H, Taylor A, Murray RM, and Poulton R (2002) Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: Results from a longitudinal birth cohort. Arch Gen Psychiatry 59:449-456.
34. Caroni P, Chowdhury A, and Lahr M (2014) Synapse rearrangements upon learning: from divergent-sparse connectivity to dedicated sub-circuits. Trends Neurosci 37: 604-614.
35. Catts VS, Fung SJ, Long LE, Joshi D, Vercammen A, Allen KM, Fillman SG, Rothmond DA, Sinclair D, and Tiwari Y, et al. (2013) Rethinking schizophrenia in the context of normal neurodevelopment. Front Cell Neurosci 7:60.
36. Chan RCK, Di X, McAlonan GM, and Gong QY (2011) Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: An activation likelihood estimation meta- Analysis of illness progression. Schizophr Bull 37: 177-188.
37. Chan RCK, Xu T, Heinrichs RW, Yu Y, and Wang Y (2010) Neurological soft signs in schizophrenia: A meta- Analysis. Schizophr Bull 36:1089-1104.
38. Chaves C, Marque CR, Maia-de-Oliveira JP, Wichert-Ana L, Ferrari TB, Santos AC, Araújo D, Machado-de-Sousa JP, Bressan RA, and Elkis H, et al. (2015) Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia. Schizophr Res 161:439-445.
39. Chen HB, Chan YT, Hung AC, Tsai YC, and Sun SH (2006) Elucidation of ATPstimulated stress protein expression of RBA-2 type-2 astrocytes: ATP potentiate HSP60 and Cu/Zn SOD expression and stimulates pI shift of peroxiredoxin II. J Cell Biochem 97:314-326.
40. Cheon KA, Kim YS, Oh SH, Park SY, Yoon HW, Herrington J, Nair A, Koh YJ, Jang DP, and Kim YB, et al. (2011) Involvement of the anterior thalamic radiation in boys with high functioning autism spectrum disorders: A Diffusion Tensor Imaging study. Brain Res 1417:77-86.
41. Choi YK and Kim KW (2008) Blood-neural barrier: its diversity and coordinated cellto- cell communication. BMB Rep 41:345-352.
42. Clarner T, Janssen K, Nellessen L, Stangel M, Skripuletz T, Krauspe B, Hess F-M, Denecke B, Beutner C, and Linnartz-Gerlach B, et al. (2015) CXCL10 triggers early microglial activation in the cuprizone model. J Immunol 194:3400-3413.
43. Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, Barnes CC, and Pierce K (2011) Neuron number and size in prefrontal cortex of children with autism. JAMA 306:2001-2010.
44. Couture SM, Penn DL, and Roberts DL (2006) The functional significance of social cognition in schizophrenia: A review. Schizophr Bull 32 (Suppl1):S44-S63.
45. Davies P, Marken F, Salter S, and Brown DR (2009) Thermodynamic and voltammetric characterization of the metal binding to the prion protein: insights into pH dependence and redox chemistry. Biochemistry 48:2610-2619.
46. Dawson G, Meltzoff AN, Osterling J, and Rinaldi J (1998) Neuropsychological correlates of early symptoms of autism. Child Dev 69:1276-1285.
47. Dichter GS (2012) Functional magnetic resonance imaging of autism spectrum disorders. Dialogues Clin Neurosci 14:319-351.
48. Dusek P, Roos PM, Litwin T, Schneider SA, Flaten TP, and Aaseth J (2015) The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases. J Trace Elem Med Biol 31:193-203.
49. Dziegielewska KM, Ek J, Habgood MD, and Saunders NR (2001) Development of the choroid plexus. Microsc Res Tech 52:5-20.
50. Faber S, Zinn GM, Kern JC 2nd, and Kingston HMS (2009) The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers 14:171-180.
51. Fan FM, Tan SP, Yang FD, Tan YL, Zhao YL, Chen N, Li BB, Song CS, Wang YH, and Jin Z, et al. (2013) Ventral medial prefrontal functional connectivity and emotion regulation in chronic schizophrenia: A pilot study. Neurosci Bull 29:59-74.
52. Ferrarelli F, Peterson MJ, Sarasso S, Riedner BA, Murphy MJ, Benca RM, Bria P, Kalin NH, and Tononi G (2010) Thalamic dysfunction in schizophrenia suggested by whole-night deficits in slow and fast spindles. Am J Psychiatry 167:1339-1348.
53. Frazier TW, Thompson L, Youngstrom EA, Law P, Hardan AY, Eng C, and Morris N (2014) A twin study of heritable and shared environmental contributions to autism. J Autism Dev Disord 44:2013-2025.
54. Fujii E, Mori K, Miyazaki M, Hashimoto T, Harada M, and Kagami S (2010) Function of the frontal lobe in autistic individuals: A proton magnetic resonance spectroscopic study. J Med Invest 57:35-44.
55. Fujita E, Dai H, Tanabe Y, Zhiling Y, Yamagata T, Miyakawa T, Tanokura M, Momoi MY, and Momoi T (2010) Autism spectrum disorder is related to endoplasmic reticulum stress induced by mutations in the synaptic cell adhesion molecule, CADM1. Cell Death Dis 1:e47.
56. Fujita E, Tanabe Y, Shiota A, Ueda M, Suwa K, Momoi MY, and Momoi T (2008) Ultrasonic vocalization impairment of Foxp2 (R552H) knockin mice related to speech-language disorder and abnormality of Purkinje cells. Proc Natl Acad Sci USA 105:3117-3122.
57. Fujita-Jimbo E, Tanabe Y, Yu Z, Kojima K, Mori M, Li H, Iwamoto S, Yamagata T, Momoi MY, and Momoi T (2015) The association of GPR85 with PSD-95-neuroligin complex and autism spectrum disorder: A molecular analysis. Mol Autism 6:17.
58. Fujita-Jimbo E, Yu ZL, Li H, Yamagata T, Mori M, Momoi T, and Momoi MY (2012) Mutation in Parkinson disease- Associated, G-protein-coupled receptor 37 (GPR37/PaelR) is related to autism spectrum disorder. PLoS One 7:e51155.
59. Gardener H, Spiegelman D, and Buka SL (2009) Prenatal risk factors for autism: comprehensive meta- Analysis. Br J Psychiatry 195:7-14.
60. Gardener H, Spiegelman D, and Buka SL (2011) Perinatal and neonatal risk factors for autism: A comprehensive meta- Analysis. Pediatrics 128:344-355.
61. Garrido-Mesa N, Zarzuelo A, and Gálvez J (2013) Minocycline: far beyond an antibiotic. Br J Pharmacol 169:337-352.
62. Gejman PV, Sanders AR, and Duan J (2010) The role of genetics in the etiology of schizophrenia. Psychiatr Clin North Am 33:35-66.
63. Gervais H, Belin P, Boddaert N, Leboyer M, Coez A, Sfaello I, Barthélémy C, Brunelle F, Samson Y, and Zilbovicius M (2004) Abnormal cortical voice processing in autism. Nat Neurosci 7:801-802.
64. Geyer MA and Vollenweider FX (2008) Serotonin research: contributions to understanding psychoses. Trends Pharmacol Sci 29:445-453.
65. Ghanizadeh A, Dehbozorgi S, OmraniSigaroodi M, and Rezaei Z (2014) Minocycline as add-on treatment decreases the negative symptoms of schizophrenia; a randomized placebo-controlled clinical trial. Recent Pat Inflamm Allergy Drug Discov 8:211-215.
66. Glasson EJ, Bower C, Petterson B, de Klerk N, Chaney G, and Hallmayer JF (2004) Perinatal factors and the development of autism: A population study. Arch Gen Psychiatry 61:618-627.
67. Gordon S and Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32:593-604.
68. Gottfried C, Bambini-Junior V, Francis F, Riesgo R, and Savino W (2015) The impact of neuroimmune alterations in autism spectrum disorder. Front Psychiatry 6:121.
69. Groebe A, Clarner T, Baumgartner W, Dang J, Beyer C, and Kipp M (2009) Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum. Cerebellum 8:163-174.
70. Guastella AJ, Einfeld SL, Gray KM, Rinehart NJ, Tonge BJ, Lambert TJ, and Hickie IB (2010) Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry 67:692-694.
71. Gudi V, Moharregh-Khiabani D, Skripuletz T, Koutsoudaki PN, Kotsiari A, Skuljec J, Trebst C, and Stangel M (2009) Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res 1283:127-138.
72. Guinchat V, Thorsen P, Laurent C, Cans C, Bodeau N, and Cohen D (2012) Pre-, periand neonatal risk factors for autism. Acta Obstet Gynecol Scand 91:287-300.
73. Gunter TE, Gerstner B, Gunter KK, Malecki J, Gelein R, Valentine WM, Aschner M, and Yule DI (2013) Manganese transport via the transferrin mechanism. Neurotoxicology 34:118-127.
74. Hackett TA (2015) Anatomic organization of the auditory cortex. Handb Clin Neurol 129:27-53.
75. Hardan AY, Girgis RR, Adams J, Gilbert AR, Keshavan MS, and Minshew NJ (2006) Abnormal brain size effect on the thalamus in autism. Psychiatry Res 147:145-151.
76. Hardan AY, Minshew NJ, Melhem NM, Srihari S, Jo B, Bansal R, Keshavan MS, and Stanley JA (2008) An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res 163:97-105.
77. Hassel S, Almeida JRC, Kerr N, Nau S, Ladouceur CD, Fissell K, Kupfer DJ, and Phillips ML (2008) Elevated striatal and decreased dorsolateral prefrontal cortical activity in response to emotional stimuli in euthymic bipolar disorder: no associations with psychotropic medication load. Bipolar Disord 10:916-927.
78. Heatherton TF and Wagner DD (2011) Cognitive neuroscience of self-regulation failure. Trends Cogn Sci 15:132-139.
79. Heo Y, Zhang Y, Gao D, Miller VM, and Lawrence DA (2011) Aberrant immune responses in a mouse with behavioral disorders. PLoS One 6:e20912.
80. Hultman CM, Sparén P, Takei N, Murray RM, and Cnattingius S (1999) Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study. BMJ 318:421-426.
81. Jackson SP (2011) Arterial thrombosis: insidious, unpredictable and deadly. Nat Med 17:1423-1436.
82. Kalmady SV, Venkatasubramanian G, Shivakumar V, Gautham S, Subramaniam A, Jose DA, Maitra A, Ravi V, and Gangadhar BN (2014) Relationship between interleukin-6 gene polymorphism and hippocampal volume in antipsychotic-naive schizophrenia: Evidence for differential susceptibility? PLoS One 9:e96021.
83. Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P, Lepack A, Majik MS, Jeong LS, and Banasr M, et al. (2012) Decreased expression of synapserelated genes and loss of synapses in major depressive disorder. Nat Med 18: 1413-1417.
84. Kelly DL, Sullivan KM, McEvoy JP, McMahon RP, Wehring HJ, Gold JM, Liu F, Warfel D, Vyas G, and Richardson CM, et al. (2015) Adjunctive minocycline in clozapine- Treated schizophrenia patients with persistent symptoms. J Clin Psychopharmacol 35:374-381.
85. Kettenmann H, Hanisch U-K, Noda M, and Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91:461-553.
86. Khan S, Gramfort A, Shetty NR, Kitzbichler MG, Ganesan S, Moran JM, Lee SM, Gabrieli JDE, Tager-Flusberg HB, and Joseph RM, et al. (2013) Local and longrange functional connectivity is reduced in concert in autism spectrum disorders. Proc Natl Acad Sci USA 110:3107-3112.
87. Kiernan JA (2012) Anatomy of the temporal lobe. Epilepsy Res Treat 2012:176157.
88. Kleinhans NM, Richards T, Sterling L, Stegbauer KC, Mahurin R, Johnson LC, Greenson J, Dawson G, and Aylward E (2008) Abnormal functional connectivity in autism spectrum disorders during face processing. Brain 131:1000-1012.
89. Kobayashi K, Imagama S, Ohgomori T, Hirano K, Uchimura K, Sakamoto K, Hirakawa A, Takeuchi H, Suzumura A, and Ishiguro N, et al. (2013) Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis 4:e525.
90. Koutsoudaki PN, Skripuletz T, Gudi V, Moharregh-Khiabani D, Hildebrandt H, Trebst C, and Stangel M (2009) Demyelination of the hippocampus is prominent in the cuprizone model. Neurosci Lett 451:83-88.
91. Koyama R and Ikegaya Y (2015) Microglia in the pathogenesis of autism spectrum disorders. Neurosci Res 100:1-5.
92. Koziol LF, Budding D, Andreasen N, D'Arrigo S, Bulgheroni S, Imamizu H, Ito M, Manto M, Marvel C, and Parker K, et al. (2014) Consensus paper: The cerebellum's role in movement and cognition. Cerebellum 13:151-177.
93. Kreifelts B, Ethofer T, Grodd W, Erb M, and Wildgruber D (2007) Audiovisual integration of emotional signals in voice and face: An event-related fMRI study. Neuroimage 37:1445-1456.
94. Kurt S, Fisher SE, and Ehret G (2012) Foxp2 mutations impair auditory-motor association learning. PLoS One 7:e33130.
95. Lai G, Pantazatos SP, Schneider H, and Hirsch J (2012) Neural systems for speech and song in autism. Brain 135:961-975.
96. Lai MC, Lombardo MV, Chakrabarti B, Sadek SA, Pasco G, Wheelwright SJ, Bullmore ET, Baron-Cohen S, and Suckling J; MRC AIMS Consortium (2010) A shift to randomness of brain oscillations in people with autism. Biol Psychiatry 68:1092-1099.
97. Langlet F, Mullier A, Bouret SG, Prevot V, and Dehouck B (2013) Tanycyte-like cells form a blood-cerebrospinal fluid barrier in the circumventricular organs of the mouse brain. J Comp Neurol 521:3389-3405.
98. Larson MK, Walker EF, and Compton MT (2010) Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Rev Neurother 10:1347-1359.
99. Lebel C, Walker L, Leemans A, Phillips L, and Beaulieu C (2008) Microstructural maturation of the human brain from childhood to adulthood. Neuroimage 40: 1044-1055.
100. LeBlanc JJ and Fagiolini M (2011) Autism: A "critical period" disorder? Neural Plast 2011:921680.
101. Lee CM and Bo J (2015) Motor functioning in children with autism spectrum disorder. Acta Psychopathologica 1:13.
102. Levkovitz Y, Mendlovich S, Riwkes S, Braw Y, Levkovitch-Verbin H, Gal G, Fennig S, Treves I, and Kron S (2010) A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry 71:138-149.
103. Levy BJ and Wagner AD (2011) Cognitive control and right ventrolateral prefrontal cortex: Reflexive reorienting, motor inhibition, and action updating. Ann N Y Acad Sci 1224:40-62.
104. Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T, and Malik M (2009) Elevated immune response in the brain of autistic patients. J Neuroimmunol 207:111-116.
105. Liddelow SA (2015) Development of the choroid plexus and blood-CSF barrier. Front Neurosci 9:32.
106. Lisé MF and El-Husseini A (2006) The neuroligin and neurexin families: from structure to function at the synapse. Cell Mol Life Sci 63:1833-1849.
107. LoParo D and Waldman ID (2015) The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: A meta- Analysis. Mol Psychiatry 20:640-646.
108. Lun MP, Monuki ES, and Lehtinen MK (2015) Development and functions of the choroid plexus-cerebrospinal fluid system. Nat Rev Neurosci 16:445-457.
109. Lupien SJ, Parent S, Evans AC, Tremblay RE, Zelazo PD, Corbo V, Pruessner JC, and Séguin JR (2011) Larger amygdala but no change in hippocampal volume in 10-year-old children exposed to maternal depressive symptomatology since birth. Proc Natl Acad Sci USA 108:14324-14329.
110. Marenco S and Weinberger DR (2000) The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol 12:501-527.
111. Martins VR, Mercadante AF, Cabral ALB, Freitas ARO, and Castro RMRPS (2001) Insights into the physiological function of cellular prion protein. Braz J Med Biol Res 34:585-595.
112. Mazzola V, Vuilleumier P, Latorre V, Petito A, Gallese V, Popolizio T, Arciero G, and Bondolfi G (2013) Effects of emotional contexts on cerebello- Thalamo-cortical activity during action observation. PLoS One 8:e75912.
113. McAlonan GM, Cheung V, Cheung C, Suckling J, Lam GY, Tai KS, Yip L, Murphy DGM, and Chua SE (2005) Mapping the brain in autism: A voxel-based MRI study of volumetric differences and intercorrelations in autism. Brain 128:268-276.
114. McFarlane HG, Kusek GK, Yang M, Phoenix JL, Bolivar VJ, and Crawley JN (2008) Autism-like behavioral phenotypes in BTBR T1tf/J mice. Genes Brain Behav 7:152-163.
115. McMahon EJ, Cook DN, Suzuki K, and Matsushima GK (2001) Absence of macrophage-inflammatory protein-1a delays central nervous system demyelination in the presence of an intact blood-brain barrier. J Immunol 167:2964-2971.
116. McMahon EJ, Suzuki K, and Matsushima GK (2002) Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier. J Neuroimmunol 130:32-45.
117. Meyer U, Feldon J, and Dammann O (2011a) Schizophrenia and autism: Both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res 69: 26R-33R.
118. Meyer U, Schwarz MJ, and Müller N (2011b) Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacol Ther 132:96-110.
119. Mikita J, Dubourdieu-Cassagno N, Deloire MS, Vekris A, Biran M, Raffard G, Brochet B, Canron MH, Franconi JM, and Boiziau C, et al. (2011) Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis: Amelioration of clinical status by M2 activated monocyte administration. Mult Scler 17:2-15.
120. Miles JH (2011) Autism spectrum disorders: A genetics review. Genet Med 13: 278-294.
121. Milhavet O, McMahon HEM, Rachidi W, Nishida N, Katamine S, Mangé A, Arlotto M, Casanova D, Riondel J, and Favier A, et al. (2000) Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci USA 97:13937-13942.
122. Miyazaki S, Hiraoka Y, Hidema S, and Nishimori K (2016) Prenatal minocycline treatment alters synaptic protein expression, and rescues reduced mother call rate in oxytocin receptor-knockout mice. Biochem Biophys Res Commun 472: 319-323.
123. Money KM and Stanwood GD (2013) Developmental origins of brain disorders: Roles for dopamine. Front Cell Neurosci 7:260.
124. Monk CS, Weng SJ, Wiggins JL, Kurapati N, Louro HMC, Carrasco M, Maslowsky J, Risi S, and Lord C (2010) Neural circuitry of emotional face processing in autism spectrum disorders. J Psychiatry Neurosci 35:105-114.
125. Morgan JT, Chana G, Pardo CA, Achim C, Semendeferi K, Buckwalter J, Courchesne E, and Everall IP (2010) Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 68: 368-376.
126. Mosser DM and Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958-969.
127. Mostofsky SH, Powell SK, Simmonds DJ, Goldberg MC, Caffo B, and Pekar JJ (2009) Decreased connectivity and cerebellar activity in autism during motor task performance. Brain 132:2413-2425.
128. Motzkin JC, Philippi CL, Wolf RC, Baskaya MK, and Koenigs M (2015) Ventromedial prefrontal cortex is critical for the regulation of amygdala activity in humans. Biol Psychiatry 77:276-284.
129. Mukamel Z, Konopka G, Wexler E, Osborn GE, Dong H, Bergman MY, Levitt P, and Geschwind DH (2011) Regulation of MET by FOXP2, genes implicated in higher cognitive dysfunction and autism risk. J Neurosci 31:11437-11442.
130. Nair A, Treiber JM, Shukla DK, Shih P, and Müller RA (2013) Impaired thalamocortical connectivity in autism spectrum disorder: A study of functional and anatomical connectivity. Brain 136:1942-1955.
131. Nakagawa Y and Chiba K (2014) Role of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseases. Pharmaceuticals 7:1028-1048.
132. Nakagawa Y and Chiba K (2015) Diversity and plasticity of microglial cells in psychiatric and neurological disorders. Pharmacol Ther 154:21-35.
133. Nakamura T, Furuhashi M, Li P, Cao H, Tuncman G, Sonenberg N, Gorgun CZ, and Hotamisligil GS (2010) Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 140:338-348.
134. Neggers YH (2014) Increasing prevalence, changes in diagnostic criteria, and nutritional risk factors for autism spectrum disorders. ISRN Nutr 2014:514026.
135. Okada K, Hashimoto K, Iwata Y, Nakamura K, Tsujii M, Tsuchiya KJ, Sekine Y, Suda S, Suzuki K, and Sugihara G, et al. (2007) Decreased serum levels of transforming growth factor-b1 in patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 31:187-190.
136. Onore C, Careaga M, and Ashwood P (2012) The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26:383-392.
137. Orsini CA and Maren S (2012) Neural and cellular mechanisms of fear and extinction memory formation. Neurosci Biobehav Rev 36:1773-1802.
138. Palaniyappan L, Simmonite M, White TP, Liddle EB, and Liddle PF (2013) Neural primacy of the salience processing system in schizophrenia. Neuron 79:814-828.
139. Pankow A, Friedel E, Sterzer P, Seiferth N, Walter H, Heinz A, and Schlagenhauf F (2013) Altered amygdala activation in schizophrenia patients during emotion processing. Schizophr Res 150:101-106.
140. Pasquini LA, Calatayud CA, Bertone Uña AL, Millet V, Pasquini JM, and Soto EF (2007) The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem Res 32: 279-292.
141. Patterson PH (2011) Maternal infection and immune involvement in autism. Trends Mol Med 17:389-394.
142. Peluffo H, Acarin L, Faiz M, Castellano B, and Gonzalez B (2005) Cu/Zn superoxide dismutase expression in the postnatal rat brain following an excitotoxic injury. J Neuroinflammation 2:12.
143. Phillipson M and Kubes P (2011) The neutrophil in vascular inflammation. Nat Med 17:1381-1390.
144. Pilowsky T, Yirmiya N, Arbelle S, and Mozes T (2000) Theory of mind abilities of children with schizophrenia, children with autism, and normally developing children. Schizophr Res 42:145-155.
145. Potschka H, Baltes S, Fedrowitz M, and Löscher W (2011) Impact of seizure activity on free extracellular phenytoin concentrations in amygdala-kindled rats. Neuropharmacology 61:909-917.
146. Pusic KM, Pusic AD, Kemme J, and Kraig RP (2014) Spreading depression requires microglia and is decreased by their M2a polarization from environmental enrichment. Glia 62:1176-1194.
147. Ramasamy I, Law M, Collins S, and Brooke F (2003) Organ distribution of prion proteins in variant Creutzfeldt-Jakob disease. Lancet Infect Dis 3:214-222.
148. Ransohoff RM and Perry VH (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27:119-145.
149. Redcay E (2008) The superior temporal sulcus performs a common function for social and speech perception: implications for the emergence of autism. Neurosci Biobehav Rev 32:123-142.
150. Reichenberg A, Weiser M, Rabinowitz J, Caspi A, Schmeidler J, Mark M, Kaplan Z, and Davidson M (2002) A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am J Psychiatry 159:2027-2035.
151. Rogers TD, McKimm E, Dickson PE, Goldowitz D, Blaha CD, and Mittleman G (2013) Is autism a disease of the cerebellum? An integration of clinical and pre-clinical research. Front Syst Neurosci 7:15.
152. Rosenberg RE, Law JK, Yenokyan G, McGready J, Kaufmann WE, and Law PA (2009) Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med 163:907-914.
153. Rossignol DA, Genuis SJ, and Frye RE (2014) Environmental toxicants and autism spectrum disorders: A systematic review. Transl Psychiatry 4:e360.
154. Roullet FI, Lai JKY, and Foster JA (2013) In utero exposure to valproic acid and autism: A current review of clinical and animal studies. Neurotoxicol Teratol 36:47-56.
155. Saijo K and Glass CK (2011) Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11:775-787.
156. Sato W, Toichi M, Uono S, and Kochiyama T (2012) Impaired social brain network for processing dynamic facial expressions in autism spectrum disorders. BMC Neurosci 13:99.
157. Saunders NR, Dreifuss JJ, Dziegielewska KM, Johansson PA, Habgood MD, Møllgård K, and Bauer HC (2014) The rights and wrongs of blood-brain barrier permeability studies: A walk through 100 years of history. Front Neurosci 8:404.
158. Sawa T, Kodaira M, Oiji A, Sasayama D, Iwadare Y, Ushijima H, Usami M, Watanabe K, and Saito K (2013) Dysfunction of orbitofrontal and dorsolateral prefrontal cortices in children and adolescents with high-functioning pervasive developmental disorders. Ann Gen Psychiatry 12:31.
159. Schmahmann JD and Sherman JC (1998) The cerebellar cognitive affective syndrome. Brain 121:561-579.
160. Schultz RT (2005) Developmental deficits in social perception in autism: The role of the amygdala and fusiform face area. Int J Dev Neurosci 23:125-141.
161. Schumann CM, Hamstra J, Goodlin-Jones BL, Lotspeich LJ, Kwon H, Buonocore MH, Lammers CR, Reiss AL, and Amaral DG (2004) The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J Neurosci 24:6392-6401.
162. Scott-Van Zeeland AA, Abrahams BS, Alvarez-Retuerto AI, Sonnenblick LI, Rudie JD, Ghahremani D, Mumford JA, Poldrack RA, Dapretto M, and Geschwind DH, et al. (2010) Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci Transl Med 2:56ra80.
163. Sealey LA, Hughes BW, Sriskanda AN, Guest JR, Gibson AD, Johnson-Williams L, Pace DG, and Bagasra O (2016) Environmental factors in the development of autism spectrum disorders. Environ Int 88:288-298.
164. Shalev H, Serlin Y, and Friedman A (2009) Breaching the blood-brain barrier as a gate to psychiatric disorder. Cardiovasc Psychiatry Neurol 2009:278531.
165. Shinn AK, Baker JT, Lewandowski KE, Öngür D, and Cohen BM (2015) Aberrant cerebellar connectivity in motor and association networks in schizophrenia. Front Hum Neurosci 9:134.
166. Shu W, Cho JY, Jiang Y, Zhang M, Weisz D, Elder GA, Schmeidler J, De Gasperi R, Sosa MAG, and Rabidou D, et al. (2005) Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene. Proc Natl Acad Sci USA 102:9643-9648.
167. Sidrak S, Yoong T, and Woolfenden S (2014) Iron deficiency in children with global developmental delay and autism spectrum disorder. J Paediatr Child Health 50: 356-361.
168. Sisó S, Jeffrey M, and González L (2010) Sensory circumventricular organs in health and disease. Acta Neuropathol 120:689-705.
169. Skripuletz T, Miller E, Moharregh-Khiabani D, Blank A, Pul R, Gudi V, Trebst C, and Stangel M (2010) Beneficial effects of minocycline on cuprizone induced cortical demyelination. Neurochem Res 35:1422-1433.
170. Sparks BF, Friedman SD, Shaw DW, Aylward EH, Echelard D, Artru AA, Maravilla KR, Giedd JN, Munson J, and Dawson G, et al. (2002) Brain structural abnormalities in young children with autism spectrum disorder. Neurology 59:184-192.
171. Stahl SM (2013) Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 4th ed, Cambridge University Press, Cambridge, UK.
172. Su CH and Young YH (2011) Disorders affecting the fourth ventricle: Etiology and clinical correlates. Otol Neurotol 32:1329-1335.
173. Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Futatsubashi M, Takebayashi K, Yoshihara Y, Omata K, Matsumoto K, and Tsuchiya KJ, et al. (2013) Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry 70:49-58.
174. Tager-Flusberg H (2000) Understanding the language and communicative impairments in autism, in International Review of Research on Mental Retardation (Glidden LM ed) pp 185-205, Academic Press, San Diego, CA.
175. Takahashi E, Ohki K, and Kim DS (2007) Diffusion tensor studies dissociated two fronto- Temporal pathways in the human memory system. Neuroimage 34:827-838.
176. Tamietto M and de Gelder B (2010) Neural bases of the non-conscious perception of emotional signals. Nat Rev Neurosci 11:697-709.
177. Tamura R, Kitamura H, Endo T, Hasegawa N, and Someya T (2010) Reduced thalamic volume observed across different subgroups of autism spectrum disorders. Psychiatry Res 184:186-188.
178. Tanaka SC, Doya K, Okada G, Ueda K, Okamoto Y, and Yamawaki S (2004) Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops. Nat Neurosci 7:887-893.
179. Tanaka T, Murakami K, Bando Y, and Yoshida S (2013) Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizoneinduced demyelination. J Neurochem 127:259-270.
180. Tetreault NA, Hakeem AY, Jiang S, Williams BA, Allman E, Wold BJ, and Allman JM (2012) Microglia in the cerebral cortex in autism. J Autism Dev Disord 42:2569-2584.
181. Tsatsanis KD, Rourke BP, Klin A, Volkmar FR, Cicchetti D, and Schultz RT (2003) Reduced thalamic volume in high-functioning individuals with autism. Biol Psychiatry 53:121-129.
182. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, and Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57:67-81.
183. Volkmar F, Siegel M, Woodbury-Smith M, King B, McCracken J, and State M; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI) (2014) Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 53:237-257.
184. Vuilleumier P and Pourtois G (2007) Distributed and interactive brain mechanisms during emotion face perception: Evidence from functional neuroimaging. Neuropsychologia 45:174-194.
185. Wang SSH, Kloth AD, and Badura A (2014) The cerebellum, sensitive periods, and autism. Neuron 83:518-532.
186. Weinberger DR (1986) The pathogenesis of schizophrenia: A neurodevelopmental theory, in The Neurology of Schizophrenia (Nasrallah HAW and Weinberger DR eds) pp 397-406, Elsevier, Amsterdam.
187. Weinstein M, Ben-Sira L, Levy Y, Zachor DA, Ben Itzhak E, Artzi M, Tarrasch R, Eksteine PM, Hendler T, and Ben Bashat D (2011) Abnormal white matter integrity in young children with autism. Hum Brain Mapp 32:534-543.
188. Weissman DH, Perkins AS, and Woldorff MG (2008) Cognitive control in social situations: A role for the dorsolateral prefrontal cortex. Neuroimage 40:955-962.
189. Wilson S and Argyropoulos S (2012) Sleep in schizophrenia: Time for closer attention. Br J Psychiatry 200:273-274.
190. World Health Organization (2016) http://www.who.int/whr/2002/chapter4/en/index3.html.
191. Xiang AH, Wang X, Martinez MP, Walthall JC, Curry ES, Page K, Buchanan TA, Coleman KJ, and Getahun D (2015) Association of maternal diabetes with autism in offspring. JAMA 313:1425-1434.
192. Yamamoto N and Kuwata K (2009) Difference in redox behaviors between copper-binding octarepeat and nonoctarepeat sites in prion protein. J Biol Inorg Chem 14:1209-1218.
193. Yasuda H, Yasuda Y, and Tsutsui T (2013) Estimation of autistic children by metallomics analysis. Sci Rep 3:1199.
194. Yasuda H, Yoshida K, Yasuda Y, and Tsutsui T (2011) Infantile zinc deficiency: Association with autism spectrum disorders. Sci Rep 1:129.
195. Zatta P, Raso M, Zambenedetti P, Wittkowski W, Messori L, Piccioli F, Mauri PL, and Beltramini M (2005) Copper and zinc dismetabolism in the mouse brain upon chronic cuprizone treatment. Cell Mol Life Sci 62:1502-1513.
196. Zhiling Y, Fujita E, Tanabe Y, Yamagata T, Momoi T, and Momoi MY (2008) Mutations in the gene encoding CADM1 are associated with autism spectrum disorder. Biochem Biophys Res Commun 377:926-929.